메뉴 건너뛰기




Volumn 59, Issue 2, 2012, Pages 142-149

Effects of pantoprazole as a HIF-1α inhibitor on human gastric adenocarcinoma sgc-7901 cells

Author keywords

Gastric cancer; HIF 1a; Proton pump inhibitors

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PANTOPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; HIF1A PROTEIN, HUMAN;

EID: 84863822889     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_019     Document Type: Article
Times cited : (13)

References (37)
  • 1
    • 0029051439 scopus 로고
    • Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
    • WANG GL, JIANG BH, RUE EA, SEMENZA GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514. http://dx.doi.org/10.1073/pnas.92.12.5510
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 5510-5514
    • Wang, G.L.1    Jiang, B.H.2    Rue, E.A.3    Semenza, G.L.4
  • 2
    • 0028816847 scopus 로고
    • Purification and characterization of hypoxia-inducible factor 1
    • WANG GL, SEMENZA GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270: 1230-1237. http://dx.doi.org/10.1074/jbc.270.3.1230
    • (1995) J Biol Chem , vol.270 , pp. 1230-1237
    • Wang, G.L.1    Semenza, G.L.2
  • 4
    • 70350452792 scopus 로고    scopus 로고
    • Targeting the hypoxia-inducible factor (HIF) pathway in cancer
    • POON E, HARRIS AL, ASHCROFT M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 2009; 11: e26. http://dx.doi.org/10.1017/S1462399409001173
    • (2009) Expert Rev Mol Med , vol.11
    • Poon, E.1    Harris, A.L.2    Ashcroft, M.3
  • 5
    • 34547121206 scopus 로고    scopus 로고
    • Hypoxia in cancer: Significance and impact on clinical outcome
    • VAUPEL P, MAYER A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225-239. http://dx.doi.org/10.1007/s10555-007-9055-1
    • (2007) Cancer Metastasis Rev , vol.26 , pp. 225-239
    • Vaupel, P.1    Mayer, A.2
  • 6
    • 34547124062 scopus 로고    scopus 로고
    • Hypoxia: A key regulator of angiogenesis in cancer
    • LIAO D, JOHNSON RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007;26: 281-290. http://dx.doi.org/10.1007/s10555-007-9066-y
    • (2007) Cancer Metastasis Rev , vol.26 , pp. 281-290
    • Liao, D.1    Johnson, R.S.2
  • 7
    • 10744231706 scopus 로고    scopus 로고
    • 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
    • MABJEESH NJ, ESCUIN D, LAVALLEE TM, PRIBLUDA VS, SWARTZ GM et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3: 363-375. http://dx.doi.org/10.1016/S1535-6108(03)00077-1
    • (2003) Cancer Cell , vol.3 , pp. 363-375
    • Mabjeesh, N.J.1    Escuin, D.2    Lavallee, T.M.3    Pribluda, V.S.4    Swartz, G.M.5
  • 8
    • 79952706449 scopus 로고    scopus 로고
    • miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
    • BOU KHEIR T, FUTOMA-KAZMIERCZAK E, JACOBSEN A, KROGH A, BARDRAM L et al. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29. http://dx.doi.org/10.1186/1476-4598-10-29
    • (2011) Mol Cancer , vol.10 , pp. 29
    • Bou Kheir, T.1    Futoma-Kazmierczak, E.2    Jacobsen, A.3    Krogh, A.4    Bardram, L.5
  • 9
    • 33747097563 scopus 로고    scopus 로고
    • Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas
    • MIZOKAMI K, KAKEJI Y, ODA S, IRIE K, YONEMURA T et al. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 2006; 94: 149-154. http://dx.doi.org/10.1002/jso.20568
    • (2006) J Surg Oncol , vol.94 , pp. 149-154
    • Mizokami, K.1    Kakeji, Y.2    Oda, S.3    Irie, K.4    Yonemura, T.5
  • 10
    • 33749016506 scopus 로고    scopus 로고
    • Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer
    • SUMIYOSHI Y, KAKEJI Y, EGASHIRA A, MIZOKAMI K, ORITA H et al. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 2006; 12: 5112-5117. http://dx.doi.org/10.1158/1078-0432.CCR-05-2382
    • (2006) Clin Cancer Res , vol.12 , pp. 5112-5117
    • Sumiyoshi, Y.1    Kakeji, Y.2    Egashira, A.3    Mizokami, K.4    Orita, H.5
  • 11
    • 33645241816 scopus 로고    scopus 로고
    • Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma
    • URANO N, FUJIWARA Y, DOKI Y, TSUJIE M, YAMAMOTO H et al. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 2006; 9: 44-49. http://dx.doi.org/10.1007/s10120-005-0356-1
    • (2006) Gastric Cancer , vol.9 , pp. 44-49
    • Urano, N.1    Fujiwara, Y.2    Doki, Y.3    Tsujie, M.4    Yamamoto, H.5
  • 12
    • 33846189403 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
    • GRIFFITHS EA, PRITCHARD SA, VALENTINE HR, WHITCHELO N, BISHOP PW et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer 2007; 96: 95-103. http://dx.doi. org/10.1038/sj.bjc.6603524
    • (2007) Br J Cancer , vol.96 , pp. 95-103
    • Griffiths, E.A.1    Pritchard, S.A.2    Valentine, H.R.3    Whitchelo, N.4    Bishop, P.W.5
  • 13
    • 0037414180 scopus 로고    scopus 로고
    • YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1
    • YEO EJ, CHUN YS, CHO YS, KIM J, LEE JC et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst 2003;95: 516-525. http://dx.doi. org/10.1093/jnci/95.7.516
    • (2003) J Natl Cancer Inst , vol.95 , pp. 516-525
    • Yeo, E.J.1    Chun, Y.S.2    Cho, Y.S.3    Kim, J.4    Lee, J.C.5
  • 14
    • 2942685341 scopus 로고    scopus 로고
    • Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation
    • STOELTZING O, MCCARTY MF, WEY JS, FAN F, LIU W et al. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004;96: 946-956. http://dx.doi.org/10.1093/jnci/djh168
    • (2004) J Natl Cancer Inst , vol.96 , pp. 946-956
    • Stoeltzing, O.1    McCarty, M.F.2    Wey, J.S.3    Fan, F.4    Liu, W.5
  • 15
    • 11144226693 scopus 로고    scopus 로고
    • Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells
    • YEO M, KIM DK, KIM YB, OH TY, LEE JE et al. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 2004; 10: 8687-8696. http://dx.doi.org/10.1158/1078-0432.CCR-04-1065
    • (2004) Clin Cancer Res , vol.10 , pp. 8687-8696
    • Yeo, M.1    Kim, D.K.2    Kim, Y.B.3    Oh, T.Y.4    Lee, J.E.5
  • 16
    • 0033870727 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
    • RYAN HE, POLONI M, MCNULTY W, ELSON D, GASSMANN M et al. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 2000; 60: 4010-4015.
    • (2000) Cancer Res , vol.60 , pp. 4010-4015
    • Ryan, H.E.1    Poloni, M.2    McNulty, W.3    Elson, D.4    Gassmann, M.5
  • 17
    • 34047132303 scopus 로고    scopus 로고
    • Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression
    • FANG J, ZHOU Q, LIU LZ, XIA C, HU X et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis 2007; 28: 858-864. http://dx.doi.org/10.1093/carcin/bgl205
    • (2007) Carcinogenesis , vol.28 , pp. 858-864
    • Fang, J.1    Zhou, Q.2    Liu, L.Z.3    Xia, C.4    Hu, X.5
  • 18
    • 77950222705 scopus 로고    scopus 로고
    • Granulosa cell tumor with activated mTOR-HIF-1α-VEGF pathway
    • MIYAZAWA M, YASUDA M, FUJITA M, HIRABAYASHI K, HIRASAWA T et al. Granulosa cell tumor with activated mTOR-HIF-1α-VEGF pathway. J Obstet Gynaecol Res 2010; 36: 448-453. http://dx.doi.org/10.1111/j.1447-0756.2009.01127.x
    • (2010) J Obstet Gynaecol Res , vol.36 , pp. 448-453
    • Miyazawa, M.1    Yasuda, M.2    Fujita, M.3    Hirabayashi, K.4    Hirasawa, T.5
  • 19
    • 0032581277 scopus 로고    scopus 로고
    • Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
    • CARMELIET P, DOR Y, HERBERT JM, FUKUMURA D, BRUSSELMANS K et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490. http://dx.doi.org/10.1038/28867
    • (1998) Nature , vol.394 , pp. 485-490
    • Carmeliet, P.1    Dor, Y.2    Herbert, J.M.3    Fukumura, D.4    Brusselmans, K.5
  • 20
    • 0032568150 scopus 로고    scopus 로고
    • Stabilization of wild-type p53 by hypoxia-inducible factor 1α
    • AN WG, KANEKAL M, SIMON MC, MALTEPE E, BLAGOSKLONNY MV et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 1998; 392: 405-408. http://dx.doi.org/10.1038/32925
    • (1998) Nature , vol.392 , pp. 405-408
    • An, W.G.1    Kanekal, M.2    Simon, M.C.3    Maltepe, E.4    Blagosklonny, M.V.5
  • 21
    • 69249211007 scopus 로고    scopus 로고
    • Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells
    • CHEN M, ZOU X, LUO H, CAO J, ZHANG X et al. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int 2009; 33: 1008-1019. http://dx.doi.org/10.1016/j.cellbi.2009.05.004
    • (2009) Cell Biol Int , vol.33 , pp. 1008-1019
    • Chen, M.1    Zou, X.2    Luo, H.3    Cao, J.4    Zhang, X.5
  • 22
    • 77958033377 scopus 로고    scopus 로고
    • Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
    • BÖDVARSDÓTTIR TB, HOVE KD, GOTFREDSEN CF, PRIDAL L, VAAG A et al. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. Diabetologia 2010; 53: 2220-2223. http://dx.doi.org/10.1007/s00125-010-1825-6
    • (2010) Diabetologia , vol.53 , pp. 2220-2223
    • Bödvarsdóttir, T.B.1    Hove, K.D.2    Gotfredsen, C.F.3    Pridal, L.4    Vaag, A.5
  • 23
    • 70349308397 scopus 로고    scopus 로고
    • Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1
    • TAKAGI T, NAITO Y, OKADA H, ISHII T, MIZUSHIMA K et al. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. J Pharmacol Exp Ther 2009; 331: 255-264. http://dx.doi. org/10.1124/jpet.109.152702
    • (2009) J Pharmacol Exp Ther , vol.331 , pp. 255-264
    • Takagi, T.1    Naito, Y.2    Okada, H.3    Ishii, T.4    Mizushima, K.5
  • 24
    • 34347354298 scopus 로고    scopus 로고
    • Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: Evaluation of mechanisms
    • SCHILLINGER W, TEUCHER N, SOSSALLA S, KETTLEWELL S, WERNER C et al. Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. Circulation 2007; 116: 57-66. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.666008
    • (2007) Circulation , vol.116 , pp. 57-66
    • Schillinger, W.1    Teucher, N.2    Sossalla, S.3    Kettlewell, S.4    Werner, C.5
  • 25
    • 2942724235 scopus 로고    scopus 로고
    • mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
    • MAJUMDER PK, FEBBO PG, BIKOFF R, BERGER R, XUE Q et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10: 594-601. http://dx.doi.org/10.1038/nm1052
    • (2004) Nat Med , vol.10 , pp. 594-601
    • Majumder, P.K.1    Febbo, P.G.2    Bikoff, R.3    Berger, R.4    Xue, Q.5
  • 26
    • 33744829237 scopus 로고    scopus 로고
    • CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1α/VEGF Signaling
    • WAN X, SHEN N, MENDOZA A, KHANNA C HELMAN LJ. CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1α/VEGF Signaling. Neoplasia 2006; 8: 394-401. http://dx.doi.org/10.1593/neo.05820
    • (2006) Neoplasia , vol.8 , pp. 394-401
    • Wan, X.1    Shen, N.2    Mendoza, A.3    Khanna Helman, L.J.C.4
  • 27
    • 33748742635 scopus 로고    scopus 로고
    • Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression
    • PENG XH, KARNA P, CAO Z, JIANG BH, ZHOU M et al. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006; 281: 25903-25914. http://dx.doi.org/10.1074/jbc. M603414200
    • (2006) J Biol Chem , vol.281 , pp. 25903-25914
    • Peng, X.H.1    Karna, P.2    Cao, Z.3    Jiang, B.H.4    Zhou, M.5
  • 28
    • 0037111665 scopus 로고    scopus 로고
    • BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
    • MAYERHOFER M, VALENT P, SPERR WR, GRIFFIN JD SILLABER C. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 2002; 100: 3767-3775. http://dx.doi. org/10.1182/blood-2002-01-0109
    • (2002) Blood , vol.100 , pp. 3767-3775
    • Mayerhofer, M.1    Valent, P.2    Sperr, W.R.3    Griffin Jd Sillaber, C.4
  • 29
    • 0037862921 scopus 로고    scopus 로고
    • The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: Dichotomus effect predictable by the HIF1α/VEGF pre-treatment status?
    • KOUKOURAKIS MI, SIMOPOULOS C, POLYCHRONIDIS A, PERENTE S, BOTAITIS S et al. The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIF1α/VEGF pre-treatment status? Anticancer Res 2003; 23: 1673-1680.
    • (2003) Anticancer Res , vol.23 , pp. 1673-1680
    • Koukourakis, M.I.1    Simopoulos, C.2    Polychronidis, A.3    Perente, S.4    Botaitis, S.5
  • 30
    • 0036359548 scopus 로고    scopus 로고
    • Hypoxia-a key regulatory factor in tumour growth
    • HARRIS AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47. http://dx.doi.org/10.1038/nrc704
    • (2002) Nat Rev Cancer , vol.2 , pp. 38-47
    • Harris, A.L.1
  • 31
    • 0033587146 scopus 로고    scopus 로고
    • The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
    • MAXWELL PH, WIESENER MS, CHANG GW, CLIFFORD SC, VAUX EC et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275. http://dx.doi. org/10.1038/2045
    • (1999) Nature , vol.399 , pp. 271-275
    • Maxwell, P.H.1    Wiesener, M.S.2    Chang, G.W.3    Clifford, S.C.4    Vaux, E.C.5
  • 32
    • 0035917808 scopus 로고    scopus 로고
    • Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
    • JAAKKOLA P, MOLE DR, TIAN YM, WILSON MI, GIELBERT J et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472. http://dx.doi.org/10.1126/science.1059796
    • (2001) Science , vol.292 , pp. 468-472
    • Jaakkola, P.1    Mole, D.R.2    Tian, Y.M.3    Wilson, M.I.4    Gielbert, J.5
  • 33
    • 3242725198 scopus 로고    scopus 로고
    • HIF activation by pH-dependent nucleolar sequestration of VHL
    • MEKHAIL K, GUNARATNAM L, BONICALZI ME LEE S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 2004; 6: 642-647. http://dx.doi. org/10.1038/ncb1144
    • (2004) Nat Cell Biol , vol.6 , pp. 642-647
    • Mekhail, K.1    Gunaratnam, L.2    Bonicalzi Me Lee, S.3
  • 34
    • 9744260934 scopus 로고    scopus 로고
    • Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs
    • LUCIANI F, SPADA M, MILITO AD, MOLINARI A, RIVOLTINI L et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004; 96: 1702-1713. http://dx.doi.org/10.1093/jnci/djh305
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1702-1713
    • Luciani, F.1    Spada, M.2    Milito, A.D.3    Molinari, A.4    Rivoltini, L.5
  • 35
    • 67349244880 scopus 로고    scopus 로고
    • A novel benzimidazole analogue inhibits the hypoxiainducible factor (HIF)-1 pathway
    • WON MS, IM N, PARK S, BOOVANAHALLI SK, JIN Y et al. A novel benzimidazole analogue inhibits the hypoxiainducible factor (HIF)-1 pathway. Biochem Biophys Res Commun 2009; 385: 16-21. http://dx.doi.org/10.1016/j.bbrc.2009.05.022
    • (2009) Biochem Biophys Res Commun , vol.385 , pp. 16-21
    • Won, M.S.1    Im, N.2    Park, S.3    Boovanahalli, S.K.4    Jin, Y.5
  • 36
    • 0344552888 scopus 로고    scopus 로고
    • RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation
    • HÄNZE J, EUL BG, SAVAI R, KRICK S, GOYAL P et al. RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Commun 2003; 312: 571-577. http://dx.doi.org/10.1016/j.bbrc.2003.10.153
    • (2003) Biochem Biophys Res Commun , vol.312 , pp. 571-577
    • Hänze, J.1    Eul, B.G.2    Savai, R.3    Krick, S.4    Goyal, P.5
  • 37
    • 34547493149 scopus 로고    scopus 로고
    • Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-α hydroxylases
    • BRUEGGE K, JELKMANN W METZEN E. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-α hydroxylases. Curr Med Chem 2007; 14: 1853-1862.
    • (2007) Curr Med Chem , vol.14 , pp. 1853-1862
    • Bruegge, K.1    Jelkmann Metzen, E.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.